pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-23a |
Genomic Coordinates | chr19: 13836587 - 13836659 |
Synonyms | MIRN23A, hsa-mir-23a, miRNA23A, MIR23A |
Description | Homo sapiens miR-23a stem-loop |
Comment | This miRNA was previously named miR-23 . This finding was later retracted after the discovery that the regulated gene was human homolog of ES1 (HES1), whose function is unknown. |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-23a-5p | |||||||||
Sequence | 9| GGGGUUCCUGGGGAUGGGAUUU |30 | |||||||||
Evidence | Experimental | |||||||||
Experiments | Cloned | |||||||||
SNPs in miRNA |
|
|||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | UGGT1 | ||||||||||||||||||||
Synonyms | HUGT1, UGCGL1, UGT1 | ||||||||||||||||||||
Description | UDP-glucose glycoprotein glucosyltransferase 1 | ||||||||||||||||||||
Transcript | NM_020120 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on UGGT1 | |||||||||||||||||||||
3'UTR of UGGT1 (miRNA target sites are highlighted) |
>UGGT1|NM_020120|3'UTR 1 TCTCTGGAGAAGGACAGGAAATCACCCCATTTGAAAAACAGTTTTTATAATAAATGCTAGTTTTTTCTGATCTGTCTATA 81 CAACTGCTGATAAGCCGGCTGGGCAGGAGTGCCACACCTTTTGATTCTGAGCATTTGATTCTGACTTCTGTACTCTGGTG 161 GCCACTGGATCTTTGGGATTAAAGCTCTGTTGGATTTGTACCTCAGAGGAAGACCAAGTGGCTGATCCTTTGGACTCTGT 241 AAAGAGCATTCTTCTAGTCAGAGGGTGGAATGGCAGCAGCAACTGGAAGAAAATGAGTTTTTTGGTGCCCACACCCAAGA 321 GCACACACATGCTGCACTGTCTCGGAAAGCAGGGCCAGCTAGAGCCACCATGTTCTTCCTTACCTCAGTTTACCTGCGGC 401 CTGCGCTGCACTGCAGATGCCCACCCTGCCCTGGGTCTGGCCGGCGGAAGCTCTGTCCAAGGTCCACACACCTCCAGGTT 481 TACGCCAACATCCTTGTGCCCTCCCCACCTTCTCTTCCAACGCATTAGGTGCATTGTTTAATTGAAATCCAACCAACAAT 561 TGTGTGTCAAGGCTGGTTTGGTGCAGTGGCTGGGCAAATTAATTTTGGGCCAGGATGGGGGTGGGTTGCAGTGAGGGTAG 641 GGAAAATGTCAGGAGTAGGAAGGTTCGGGGGTTAAGGGAAGGGAAGGAAGACCAGAACTGGCCATCCTCTTTTATAATCC 721 ATTAGTAGCACCATGGCTCATTTGAAATGAAAATATTACACTTATTCCCCACCCAACCGCAGTGAACTTTCTAGGTAATT 801 GTTTTGAAAACAATTTTTGTATCTGTGAAAGTCTTTGCTTTTTCTTTCCACCTTCTAGAAAAGTCTGCTACCAGTTTCCT 881 TACTGAATACAGCCATACTCAGCCCCTCTCGCATCCAGCCCGTCAGGGTCAGGGTCAGGGTCAGGCTCCCTCAAGACGAG 961 CACCGCATTGTCTGCCCTCTTTTGCGTAGGATTTTTCTCTCAGACCCAGGGGACATTGCCTTGGACTTTTCTCTACAAAT 1041 GCCCTCAGATGTAAGACCAGAAATGATTCTGCTTGTGGAACTCGTGGCTTTCTGTCCTATTTTCCTTTTATGTGAGCCCT 1121 GCAGGTTGCCTTTGGCGCCCACACCAGTTCTGTCTTCATGTCGCTGCATCGTGAAGCCCCATTTGCCTTTAGTCCCTGCT 1201 TTGTGTGTCTTCACTTCCACAGCCAGTGTTGCCCCTCAGGGCATACTTTGCTGGTGAACGGGCTGTAGAGTCTTGAGTAT 1281 GTTATTGGCCTAAGTGGGCATGAGGCCCCAGCATCCGACTCCATCTGCCAGGCTGCAGGGCACAGCAGCACTGGCATAGA 1361 CAGGCACGCTCTGTCTTCCAACGTGCACCAGCCTTTTCTTACATATTTTGCCTGTTTTTAAAAAATACGAGGAGAGGGTG 1441 CAGATGGATACTGTGCCCTCACCCTCCTAAGCCAGGTAATATATTGATGTGCAGACTTTTAAGAAATCTTAGTCTTATCA 1521 CAAATATCAAGTAATTTATTTTTTCCATTTTCAAATGCAAAAGTTAGCCTAGGAAGCCTCCCAGTCATCCTGAAGGACCT 1601 TTTGACTTTGCTTTTATAATTCTGTTAAAAATTGAGGAGGGGATTAATGAGTACAATGAAAACAAAACAAAACAAAAAAT 1681 TAAGAAGAGGAAAGCTCAAAAGAGGATAAGAGACTGAAAAGGCACCTCAGAATGGCTGCTGTGGGCAGAGTCTGTGACAT 1761 GACTTTCCCCGCCCTGCCCCTCTGTTCAGAGCAGCTGGAAAGATGGGATCAGTAAGATTAAAAAACTTTTGTTCGGCCAG 1841 GCGTGGTGGCTCACACCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGACGGATCATGAGGTCAGGAGTTCAAGACCAG 1921 CCTGGCCAATATGGTGAAACCCCGTCTCTACTAAAAATACAAAAATTAGCCGGGTGTTGTGGCTCACCCTCTATTCCCAG 2001 CTACTCGGGAGGCAGAGACAGGAGAATCGCCTGAACCCAGGAGGCAGAGGTTGCAGTGAGCTGAGATCGTGCCACTGCAC 2081 TCCAGCCTGGGTGACAGAGCGAGACTCCATCTCAGAAAACAAACAAACAAAAAGAAACTTTTGTTCAAGCTGCATCTTCA 2161 CATTGAATGAAAGCATTCAGACGGGTGACTGCTGCTGTCCACAACTGTGGGCGGAAGTGTGCCTTTTCCCAGTTTCTCGT 2241 CCAGGAGGTTGCATAGCAAATACTCAAGTCACTGGGATATATGCTTTCCAAATGCTGGCCCCCATAGCACCTTTCCCCAT 2321 GTCTTTCTACCAAGCCTCTTATGTTTAATCTGTGCAGGGAAGACAAGAGTAGACCATATTCTCTGTGTGCTGTGCATGTC 2401 CTGGTGTCACTCATTGCCTCTTATCTGTCGCCATTCTAATATAAGTCAGCTTAATAGTTGACTCTGAATAATGCAAAACC 2481 CAGCTTGCTTCCAGAATGGCCTAGGACCCTCCTCCTCCTGCCAGTTTTTTTTTTTTTTTTTGGTTCATGTGGCATAATCA 2561 TCTTTCAAAATTAACCAAATGCCCCAGAAAATGATGTTACCACTAAAATATTTTCTCCAAGAAGGCATACTGTAACAGAA 2641 AAGATAGGTAAGATATTTTTTTCCCAAGAAGTAAGAATTGATTGTGCTGAATGTTCAAACTCTGGAAACTGTTCACAGTA 2721 TGTTGTTCTTAGCTGTTATTTATATAAAGTGAATTATTTTCTCTCTCAATCATGCCATAGTGGAGACTTTTGTTTGTGAG 2801 TAAGTGACAGAGTAATATGAAATAATGTGATATGTCAGAGTGACATGCAGCATCCTGAGCCTGTTTTTATGTTCTGTGTA 2881 CAGTGGCATTTGATTGAGATCAAAGCCTGTCACAGCCTGCTGCTGGGGGTGTGGGGATATGCCAGAGTCCTGTGTTTGGT 2961 TTTAGAAGTTTACTGAATGTTTCCCACATGGAGAATAATGGATGGCATGTTAGTTTCTTTAAGAGTGGTAAAGTTGTACA 3041 TCTGTCATTGTTGCATTTCGAATTGAACACATAGATGCTTGCCTGTCTGCTTGGGTGAATGCCTCTTGGGAGAGCGAAGA 3121 TTACGTGCATGATGTATGTTAAGAAACAGTTTCCGGTCAGGCACAGTGGCTTACACCTGTAATCCCAGCACTTTGGGAAG 3201 CCGAGGCGGGCGGATTATGAGGTCAAGAGATAGAGACCATCCTGGCCAACACGGTGAAACCCCGTCTCTACTAAAAATAC 3281 AAAAATTAGCTGGGCATGGTGGCACACACCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAGGAGAATCACTTGAACCCG 3361 GGAGGTGGAGGTTGCAGTGAGCCGAGATCATGCCACTGCACTCCAGCCTGGCAATAGAGCGAGACTCCGTCTCAAAAAAA 3441 AAAAAAAAAAAAAAAAAAAAATTAAAACAGTTTCCATAAATGGAGCTTAATTTGCTCTGCTGTCCTTAAGCCCTCGTGGG 3521 TTTTTTTTTAAGAGAGTCTCATTCTGTCACCCAGGCTGGAGTGCAGTGGTGCGATCTTGGCTCACTTCAACCTCTGCCTC 3601 CCAAGTTCAAACAATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGATTACAGGCGCCTGCCACCATGCCTGGTTAATTTT 3681 TGTATTTTTAGTAGAGATGGGGTTTTACCATGTTGGTTGGCCAGGCTGATCTCAAACTCCTGACCTCAGGTGGTGATCTG 3761 CCCACCTCGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACTATGTCCGGTCAAGCCCTCGTGTTCTGAACCTTGT 3841 CAAGGCTCTGCCTGAATGAGTTTTCATCTGATTGTGGGGACCAAGTCCCTGAGTAGAGGGCCAAGAGCTAGGGACAGGGG 3921 GAAGAGACTGGCCCAGGTGGTAGGGAGGAAAGAACTCCCAGAGTTTCCTTTAGCCAGGAAACCTGCTCTACTGACCCCGT 4001 GACTTGGACAGTCAGACATCACCCTGAGAGTGACAAGTGTAAAATGACTCCCTTCCTCCCCCGCCCTCCGGAAGTATATT 4081 TAGATACTTGAAAGCAGTCCTTTTCTAAAATGGCCTTACCTATGTGGCCTGAACGATTAAAAGAAAGAACTCAGAGTTAC 4161 AAGGGAAAAAGAAAAAGAGTTACAAGGGAATTGTAGTCTTTTTCTGAATAGAATATTAGTACTGTGGTATTGCATTTCAT 4241 GGGAATGGAAATGTATTGGTAAAGCTACCTGATGGAAGCTTTCTCTTGGTAACAAAAATGGAGGGTGTATTATGTGCAGT 4321 TATTTAAATATATGTATTCCATTGTTGCGTGGTTTTTTTCCCCCCTCAAGACAGAGATTTGCTCTTGTTGCCCAGGGTGG 4401 AGTACAATGGTGTGACCTTGGCTCACTGCAACCTCTGCCTCCTGGGTTCAGGTGATTCTCCTGCCTCAGCCTTCCGAGTA 4481 GCTGGGATTACAGGTGTGCGCCACCACACCCGGCTAATTTTTGCTTTTTTTTTTTTTGAGACAGAATCTCGCTCTGTTGC 4561 TCAGGCTGGAGTGGAGTGCAGTGGCACAATCTCAGCTCACTGCAGCCTCTGCCTCCCGGGTTCAAGAGATTCTCCTGACT 4641 CAACCTCCTGAGTAGCTGGGATTACAGGTGCCTGCCACTATGCCTAGCTAATTTTTGTATTTTTAGTAGAGACGGGGTTT 4721 TGCCATGTTGGCCAGGGTGGTCTCGAACTCCTGACCTCAAGTGATCCACCCGCATCGGCCCCCCAAAGTGCTGGGATTAT 4801 AGGCGTGAACCACCGCGCCTGTCCCATTGTTGTGTAATTTTAATAATTAGTTTTTTAAGTACTTGATTTTATGGGCACAT 4881 TTTTGTGGGATGATTGGAGTTAATCAAATAAAGCTTGTCATGTGTGTAGTTTGGTAAGATAACTTCTTTAAATTCATGTT 4961 TTCTCTGCCTTGAGGTAGTGAGGGAAAGATCTTAATCAGTATTTTGGTAATTAACTGATTGAATTCAAGCAAATGAGACA 5041 TCATGAACTTCAGTGGTTATTGATATTTCAGGGTATATACCTGAAATGCCTAGAGGATACAGATTTCTCATTTCATTCTT 5121 TGGTCTTTCATTTCTCTATATACAGAAATGAAATGACACTTCTGGGAGGCAGTAGAAGCAGGAAGTCAATGAATTGAGTA 5201 GAGGGTCCCATTCCCTCAGGCTGTCATTGATCAGTGACAATTTATAAAAACAAACTGCAAAGTCTGTGGCAAGTGGCTGC 5281 CTGCTTCCTAGAAGGAGCCCATGAAGGTTAAACTCTGTGGTCGGTATTTGCAAGCGCCGGGCGTGGTGGCTCACGCCTGT 5361 AATCCTAGCACCTTGGGAGGCCAAGGCAGGCGGATCACCCGAGGTCAGGAGTTTGAGGATTTGCAAGCAAAAGGTCCTCT 5441 CCTGAGTCTTTCCCAGATACCCAGCAGTGCAGAGGCTAGCTGTGGAAGGTTGCAGTGGGACAGGAATGTATTGTATGCCT 5521 TGCCTTACTTGTCACCATTGAGATTTCCAGAGAAATGGGCATAACGTCTCTTAACAACAACAGCAGAAAGCAAAATACAT 5601 TAACTTAAGGTTGACAACAAAAGATTATCAAGTACCATGTTTTCCAACCAACCAGTTATTCGTGGTAATAATAAAATAAA 5681 GGTGGGAAAATGTTATAATTTTTAAGGAAACTGTGTACTTTAAAAATCTTCTTTATGAATATCCAATGTTACTGTAATCC 5761 TGCTCCATTAAATGCAGCATTGTTGTCAGGTGCTGCCTCTTGCTTGGGAACAGCATTGGGCTTTTAAATGTCTGCAGAAT 5841 CTCTGCGTTCGAAGGGAATTGAGAATGAACTTCCTGGTACTGTAATGAAAATAAGGTCTGCTCAACACAGTAAACGTTTC 5921 CTCTCTTCTTTAAAAAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
miRNA:Target | ---- | |||||||||
Validation Method |
|
|||||||||
Conditions | HEK293S | |||||||||
Location of target site | 3'UTR | |||||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | |||||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084043. RNA binding protein: AGO2. Condition:CLIP_arsenite_rep2
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
|||||||||
miRNA-target interactions (Provided by authors) |
|
|||||||||
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset GSM1084043 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_arsenite_rep2 |
Location of target site | ENST00000259253.6 | 3UTR | AGGAGGCAGAGGUUGCAGUGAGCUGAGAUCGUGCCAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
131 hsa-miR-23a-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT038958 | ATF1 | activating transcription factor 1 | ![]() |
1 | 1 | |||||||
MIRT057661 | LCOR | ligand dependent nuclear receptor corepressor | ![]() |
![]() |
2 | 2 | ||||||
MIRT395438 | NFKBID | NFKB inhibitor delta | ![]() |
![]() |
2 | 2 | ||||||
MIRT463884 | WNT7B | Wnt family member 7B | ![]() |
![]() |
2 | 4 | ||||||
MIRT475804 | HDGF | heparin binding growth factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT478528 | CTNS | cystinosin, lysosomal cystine transporter | ![]() |
![]() |
2 | 2 | ||||||
MIRT479278 | CHD4 | chromodomain helicase DNA binding protein 4 | ![]() |
![]() |
2 | 6 | ||||||
MIRT492564 | PPM1L | protein phosphatase, Mg2+/Mn2+ dependent 1L | ![]() |
![]() |
2 | 2 | ||||||
MIRT500353 | ZNF385A | zinc finger protein 385A | ![]() |
![]() |
2 | 2 | ||||||
MIRT509788 | CHAF1B | chromatin assembly factor 1 subunit B | ![]() |
![]() |
2 | 4 | ||||||
MIRT511566 | HIST3H2BB | histone cluster 3 H2B family member b | ![]() |
![]() |
2 | 4 | ||||||
MIRT525450 | GPATCH2L | G-patch domain containing 2 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT539558 | CNKSR3 | CNKSR family member 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT540034 | DNAJC28 | DnaJ heat shock protein family (Hsp40) member C28 | ![]() |
![]() |
2 | 4 | ||||||
MIRT540225 | SAMD5 | sterile alpha motif domain containing 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540242 | RGS17 | regulator of G protein signaling 17 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540871 | ZBTB24 | zinc finger and BTB domain containing 24 | ![]() |
![]() |
2 | 2 | ||||||
MIRT559065 | C19orf47 | chromosome 19 open reading frame 47 | ![]() |
![]() |
2 | 4 | ||||||
MIRT560685 | HIST1H1T | histone cluster 1 H1 family member t | ![]() |
![]() |
2 | 2 | ||||||
MIRT565593 | SLC35G1 | solute carrier family 35 member G1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565642 | SKI | SKI proto-oncogene | ![]() |
![]() |
2 | 2 | ||||||
MIRT576747 | Tmem127 | transmembrane protein 127 | ![]() |
![]() |
2 | 2 | ||||||
MIRT607712 | LIMS1 | LIM zinc finger domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT615682 | NAV2 | neuron navigator 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT617337 | ZSCAN2 | zinc finger and SCAN domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT617378 | FAM227A | family with sequence similarity 227 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT620855 | SERPING1 | serpin family G member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT625112 | SLC1A5 | solute carrier family 1 member 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT625124 | NUP93 | nucleoporin 93 | ![]() |
![]() |
2 | 2 | ||||||
MIRT625898 | LINC00632 | long intergenic non-protein coding RNA 632 | ![]() |
![]() |
2 | 2 | ||||||
MIRT626016 | XRCC2 | X-ray repair cross complementing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT626481 | ADAT1 | adenosine deaminase, tRNA specific 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT626573 | MED7 | mediator complex subunit 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT626814 | PRR11 | proline rich 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT628136 | HM13 | histocompatibility minor 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT630771 | MSANTD3 | Myb/SANT DNA binding domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT633133 | C6orf132 | chromosome 6 open reading frame 132 | ![]() |
![]() |
2 | 2 | ||||||
MIRT636950 | APTX | aprataxin | ![]() |
![]() |
2 | 2 | ||||||
MIRT637802 | GGPS1 | geranylgeranyl diphosphate synthase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT638622 | GSR | glutathione-disulfide reductase | ![]() |
![]() |
2 | 4 | ||||||
MIRT642196 | SMAGP | small cell adhesion glycoprotein | ![]() |
![]() |
2 | 2 | ||||||
MIRT645121 | HES2 | hes family bHLH transcription factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT645344 | AGTPBP1 | ATP/GTP binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT646564 | ALDH5A1 | aldehyde dehydrogenase 5 family member A1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT649243 | TRIM65 | tripartite motif containing 65 | ![]() |
![]() |
2 | 2 | ||||||
MIRT651810 | USP49 | ubiquitin specific peptidase 49 | ![]() |
![]() |
2 | 2 | ||||||
MIRT652137 | TRPM7 | transient receptor potential cation channel subfamily M member 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT652668 | TIMELESS | timeless circadian clock | ![]() |
![]() |
2 | 2 | ||||||
MIRT655894 | NEK9 | NIMA related kinase 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT656564 | LYRM7 | LYR motif containing 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT657194 | IKZF3 | IKAROS family zinc finger 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT657907 | GDE1 | glycerophosphodiester phosphodiesterase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT660207 | BMPR1A | bone morphogenetic protein receptor type 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT660619 | ANKS4B | ankyrin repeat and sterile alpha motif domain containing 4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT660826 | AGO3 | argonaute 3, RISC catalytic component | ![]() |
![]() |
2 | 2 | ||||||
MIRT660986 | ABHD2 | abhydrolase domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT662232 | PGBD4 | piggyBac transposable element derived 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT663691 | ZNF347 | zinc finger protein 347 | ![]() |
![]() |
2 | 2 | ||||||
MIRT665577 | TUBD1 | tubulin delta 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT666149 | SP2 | Sp2 transcription factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT666310 | SLC22A3 | solute carrier family 22 member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT666457 | SCRG1 | stimulator of chondrogenesis 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT667716 | KIAA1468 | KIAA1468 | ![]() |
![]() |
2 | 2 | ||||||
MIRT668329 | FKBP5 | FK506 binding protein 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT668370 | FBXO47 | F-box protein 47 | ![]() |
![]() |
2 | 2 | ||||||
MIRT669304 | C17orf75 | chromosome 17 open reading frame 75 | ![]() |
![]() |
2 | 2 | ||||||
MIRT669538 | ALG9 | ALG9, alpha-1,2-mannosyltransferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT671681 | ADK | adenosine kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT672177 | MRE11A | MRE11 homolog, double strand break repair nuclease | ![]() |
![]() |
2 | 2 | ||||||
MIRT673604 | HPSE | heparanase | ![]() |
![]() |
2 | 2 | ||||||
MIRT673749 | ZNF333 | zinc finger protein 333 | ![]() |
![]() |
2 | 2 | ||||||
MIRT674807 | FAM229B | family with sequence similarity 229 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT675286 | ARL10 | ADP ribosylation factor like GTPase 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT675391 | SVOP | SV2 related protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT675788 | MED28 | mediator complex subunit 28 | ![]() |
![]() |
2 | 2 | ||||||
MIRT676151 | OGFOD1 | 2-oxoglutarate and iron dependent oxygenase domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT676499 | GJD3 | gap junction protein delta 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT676621 | CSNK1E | casein kinase 1 epsilon | ![]() |
![]() |
2 | 2 | ||||||
MIRT676644 | GTDC1 | glycosyltransferase like domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT676711 | METTL14 | methyltransferase like 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT676809 | SHROOM4 | shroom family member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677036 | FOXO3 | forkhead box O3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677062 | NT5C2 | 5'-nucleotidase, cytosolic II | ![]() |
![]() |
2 | 2 | ||||||
MIRT677086 | SMIM15 | small integral membrane protein 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677193 | MURC | caveolae associated protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677273 | SNRPD1 | small nuclear ribonucleoprotein D1 polypeptide | ![]() |
![]() |
2 | 2 | ||||||
MIRT677345 | POC1A | POC1 centriolar protein A | ![]() |
![]() |
2 | 2 | ||||||
MIRT677504 | SLC10A6 | solute carrier family 10 member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677526 | OCIAD2 | OCIA domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677661 | UGGT1 | UDP-glucose glycoprotein glucosyltransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677727 | SSR1 | signal sequence receptor subunit 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677803 | PNPLA3 | patatin like phospholipase domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT678144 | SLC4A4 | solute carrier family 4 member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT678376 | VTA1 | vesicle trafficking 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT678708 | DHTKD1 | dehydrogenase E1 and transketolase domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT678868 | FAM118A | family with sequence similarity 118 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT679039 | LACTB | lactamase beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT679081 | PURB | purine rich element binding protein B | ![]() |
![]() |
2 | 2 | ||||||
MIRT679137 | SYK | spleen associated tyrosine kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT679299 | SSBP2 | single stranded DNA binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT679741 | CABP4 | calcium binding protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT679946 | AS3MT | arsenite methyltransferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT679976 | E2F2 | E2F transcription factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT683628 | MTO1 | mitochondrial tRNA translation optimization 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT683901 | PSMB9 | proteasome subunit beta 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT684172 | MOG | myelin oligodendrocyte glycoprotein | ![]() |
![]() |
2 | 2 | ||||||
MIRT684231 | C20orf144 | chromosome 20 open reading frame 144 | ![]() |
![]() |
2 | 2 | ||||||
MIRT685403 | C1orf158 | chromosome 1 open reading frame 158 | ![]() |
![]() |
2 | 2 | ||||||
MIRT686253 | ZBTB8B | zinc finger and BTB domain containing 8B | ![]() |
![]() |
2 | 2 | ||||||
MIRT687513 | NCKAP1 | NCK associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT688243 | FITM2 | fat storage inducing transmembrane protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT688315 | FAM151B | family with sequence similarity 151 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT688733 | CNDP1 | carnosine dipeptidase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT689031 | ANGPTL3 | angiopoietin like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT698207 | TMEM248 | transmembrane protein 248 | ![]() |
![]() |
2 | 2 | ||||||
MIRT699859 | SAR1A | secretion associated Ras related GTPase 1A | ![]() |
![]() |
2 | 2 | ||||||
MIRT709954 | TRUB2 | TruB pseudouridine synthase family member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT711541 | MSH3 | mutS homolog 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT712077 | WDR37 | WD repeat domain 37 | ![]() |
![]() |
2 | 2 | ||||||
MIRT715312 | POLR2E | RNA polymerase II subunit E | ![]() |
![]() |
2 | 2 | ||||||
MIRT715725 | PIAS2 | protein inhibitor of activated STAT 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT715748 | HSD11B1L | hydroxysteroid 11-beta dehydrogenase 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT717604 | DSTYK | dual serine/threonine and tyrosine protein kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT717875 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718042 | NIPAL2 | NIPA like domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718829 | CDT1 | chromatin licensing and DNA replication factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT724037 | CAMK2N2 | calcium/calmodulin dependent protein kinase II inhibitor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT733305 | TNF | tumor necrosis factor | ![]() |
1 | 0 | |||||||
MIRT734941 | HSPA1B | heat shock protein family A (Hsp70) member 1B | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT737343 | IGF2 | insulin like growth factor 2 | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT737546 | PTEN | phosphatase and tensin homolog | ![]() |
![]() |
2 | 0 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|